Monthly Archives: July 2020

Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.

Funding from the Taubman Institute has helped a team of researchers develop a new approach to treating aggressive brain tumors. Daniel Wahl, MD, PhD, a radiation oncologist and researcher at Michigan Medicine, says an existing drug used to prevent organ transplant rejection may make radiation therapy more effective for glioblastoma patients by targeting a critical…

Taubman Scholar Named Chair, Dept. of Pediatrics

The Taubman Institute congratulates Donna M. Martin, MD, PhD, who was appointed chair of the Department of Pediatrics. She also became the Ravitz Foundation Endowed Professor of Pediatrics and Communicable Diseases. Dr. Martin is the Donita B. Sullivan, M.D., Research Professor of Pediatrics and Communicable Diseases, and a professor of pediatrics and human genetics in…

Beyond Just Pictures: Multi-scale, Quantitative Imaging

Imaging studies encompass scales of resolution from molecules to patients. Join us Thursday, Aug. 20 at Noon-1 pm via Zoom for this Taubman Technology Talks webinar. Gary Luker, MD, will present several different technologies to meet demands of imaging studies and computational approaches to extract quantitative imaging data from imaging studies. Dr. Luker is a…